Home cross beta

Beta-containing COVID-19 booster vaccine found to cross-neutralize variants in non-human primates

By A Mystery Man Writer

A new paper presents preliminary evidence that a new vaccine candidate, designed to boost immunity in already immunized individuals, and containing the adjuvanted Beta spike variant protein antigen, can induce a potent cross-neutralizing antibody response in non-human primate models that is detectable for up to three months.

SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern

PDF) Beta variant COVID-19 protein booster vaccines elicit durable cross- neutralization against SARS-CoV-2 variants of concern in non-human primates

Biomedicines, Free Full-Text

Two doses of RBD-scNP vaccination protected non-human primates from

Frontiers Viral vector and nucleic acid vaccines against COVID-19: A narrative review

MVA-vectored universal beta-coronavirus vaccine design & development

Polymers Strive for Accuracy: From Sequence-Defined Polymers to mRNA Vaccines against COVID-19 and Polymers in Nucleic Acid Therapeutics

Omicron-specific booster may not be needed, U.S. monkey study finds

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic - ScienceDirect